In addition, MSI‐H tumors can upregulate immunological checkpoints such as programmed death receptor‐1 (PD‐1), programmed death ligand‐1 (PD‐L1), or PD‐L2, in order to escape the host anti‐tumor immunity. Here, CD274 is linked to neoplasm.